Highland Capital Management LLC purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the 4th quarter, Holdings Channel reports. The fund purchased 43,560 shares of the medical device company’s stock, valued at approximately $4,004,000.
Several other institutional investors have also recently added to or reduced their stakes in COO. Swedbank AB boosted its holdings in shares of Cooper Companies by 14.0% in the 4th quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock worth $149,809,000 after acquiring an additional 200,000 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in Cooper Companies by 42.1% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 20,586 shares of the medical device company’s stock worth $1,892,000 after purchasing an additional 6,102 shares in the last quarter. R Squared Ltd bought a new stake in shares of Cooper Companies during the fourth quarter worth $101,000. SteelPeak Wealth LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at $428,000. Finally, Baldwin Wealth Partners LLC MA raised its holdings in shares of Cooper Companies by 14.0% in the fourth quarter. Baldwin Wealth Partners LLC MA now owns 113,719 shares of the medical device company’s stock valued at $10,454,000 after buying an additional 13,926 shares during the last quarter. 24.39% of the stock is owned by institutional investors.
Analysts Set New Price Targets
COO has been the subject of several research reports. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Wells Fargo & Company upped their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Citigroup cut their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.
Cooper Companies Price Performance
Shares of COO opened at $98.00 on Thursday. The stock has a market cap of $19.56 billion, a P/E ratio of 50.26, a price-to-earnings-growth ratio of 2.41 and a beta of 0.99. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The stock’s 50-day moving average price is $95.91 and its two-hundred day moving average price is $99.54. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.
Cooper Companies (NASDAQ:COO – Get Free Report) last issued its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.87 earnings per share. On average, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.
About Cooper Companies
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More
- Five stocks we like better than Cooper Companies
- About the Markup Calculator
- As China Tightens Rare Earth Exports, These 3 Stocks Are in Focus
- What is the Nasdaq? Complete Overview with History
- Rebuilding the Empire: Can Dollar General Rally in 2025?
- Ride Out The Recession With These Dividend Kings
- Coinbase Gains Momentum on App Store—What It Means for the Stock
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.